Skip to main content
FQHC Talent

Cookie notice

Allow detailed analytics to improve the site?It's from us, Google and Vercel, and stays off until you accept. If you're signed in, it can link your visits across devices. Declining doesn't limit what you can use. Details & privacy.

Back to the news

Open Door stops starting puberty blockers and hormone therapy for under-19 patients

Humboldt CountyMore from California

Issue

Open Door Community Health Centers CEO Tory Starr said in a September 10, 2026 letter that the health center will no longer start hormone therapy or puberty blockers for patients under 19. It cites revised HHS grant terms and says continuing could endanger resources that support care for more than 60,000 patients.

Patients already in treatment keep their care.

Key points

  • The letter ties the change to HHS's Grants Policy Statement, which lets an award end if it no longer serves program goals or agency priorities.
  • A separate rule, CMS-2451-F, ends federal Medicaid and CHIP payment for these treatments for minors starting October 13, 2026.
  • Open Door keeps care for patients already in treatment and says all its other services are unchanged for patients of every age.

Part of

Sources for your board packet

This story's source plus 4 related stories and their sources, ready to print for your team or board.

Free. Unlocking the packet subscribes you to Intel Brief. You'll also get a short welcome series and the occasional product update. You'll be subscribed right away, with no confirmation email. Unsubscribe with one click in any issue. If you unsubscribed before, we won't re-add you. We never sell your email. You can open each source above without an email.

More in Risk & Compliance

Cite this analysis

FQHC Talent. (2026, September 10). Open Door stops starting puberty blockers and hormone therapy for under-19 patients. Source: Open Door Community Health Centers — community update from CEO Tory Starr (Sept. 10, 2026). Retrieved November 11, 2026, from https://www.fqhctalent.com/intel/open-door-under-19-hormone-therapy-hhs-grants-policy-sept-2026